viernes, 13 de septiembre de 2019

Pelosi’s drug-pricing plan is aggressive, but is it viable?

The Readout
Damian Garde

Pelosi’s drug-pricing plan is aggressive, but is it viable?

Can Moderna turn cells into tiny drug-making factories? What’s it like to cure your own rare disease? 

We discuss all that and more on the latest (Damian-less) episode of “The Readout LOUD,” STAT’s biotech podcast. First, STAT’s Lev Facher joins us to discuss the details of Pelosi’s “leaked” plan to curb sky-high prescription drug prices and whether Democrats and Republicans can find enough common ground to pass meaningful legislation. Then, we’ll break down the latest effort by the biotech unicorn Moderna to turn synthesized messenger RNA into drugs and vaccines. Finally, STAT’s Matt Herper grabs a mic to discuss his interview with a UPenn professor who nearly died five times from a rare disorder, but was saved each time by his own scientific ingenuity.

You can listen to the episode here. To listen to future episodes, be sure to sign up on iTunes, Stitcher, Spotify, or wherever you get your podcasts.

No hay comentarios: